Evaxion Biotech to Host Conference Call on EVX-01 and EVX-02 Phase 1/2a Data on July 8
COPENHAGEN, Denmark, July 07, 2021 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage biotechnology company specializing in the…
Pharmaceuticals, Biotechnology and Life Sciences
COPENHAGEN, Denmark, July 07, 2021 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage biotechnology company specializing in the…
Monthly information regarding the total number of voting rights and total number of shares of the Company as of June…
AUSTIN, Texas, July 06, 2021 (GLOBE NEWSWIRE) — XBiotech Inc.’s (NASDAQ: XBIT) (“XBiotech”) Board of Directors has declared an extraordinary…
– Dr. Sorensen to become CEO of a start-up hemostasis and thrombosis company –CAMBRIDGE, Mass., July 06, 2021 (GLOBE NEWSWIRE)…
TORONTO, July 06, 2021 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX – XLY) (OTCQX: CBWTF) (“Auxly” or the “Company”)…
Data Readout for First Four Treatment Arms Expected in the Fourth Quarter of 2021WATERTOWN, Mass., July 06, 2021 (GLOBE NEWSWIRE)…
BELTSVILLE, Md., July 06, 2021 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company discovering and developing novel,…
Data demonstrate rapid absorption and higher plasma concentrations versus an intramuscular injection (p<0.0001) Results confirm findings of initial pilot PK…
WATERTOWN, Mass., July 06, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein…
Phase 2 trial of RTX for OA pain to proceed following FDA clearance.Phase 1b data demonstrated RTX safety for a…